標準治療抵抗性の血栓性血小板減少性紫斑病に対するリツキシマブ投与のタイミングについての考察(Optimal timing of rituximab administration for refractory thrombotic thrombocytopenic purpura: a retrospective case series)

Publisher： John Wiley & Sons Inc

E-ISSN： 1883-3772|26|6|152-159

ISSN： 1883-3772

Source： NIHON KYUKYU IGAKUKAI ZASSHI: JOURNAL OF JAPANESE ASSOCIATION FOR ACUTE MEDICINE, Vol.26, Iss.6, 2015-06, pp. : 152-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclophosphamide plus rituximab appears effective in refractory thrombotic thrombocytopenic purpura

By  

Inpharma, Vol. 1, Iss. 1378, 2003-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Rifampicin: Thrombotic thrombocytopenic purpura: case report

By  

Reactions Weekly, Vol. 1, Iss. 1081, 2005-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Tacrolimus: Thrombotic thrombocytopenic purpura: case report

By  

Reactions Weekly, Vol. 1, Iss. 1211, 2008-01 ,pp. : 29-29

Adis International

Access to resources Recommend Favorite

Gemcitabine: Thrombotic thrombocytopenic purpura: case report

By  

Reactions Weekly, Vol. 1, Iss. 1237, 2009-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Bortezomib: Thrombotic thrombocytopenic purpura: case report

By  

Reactions Weekly, Vol. 1, Iss. 1354, 2011-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite